BioStem secures up to $40M committed equity facility with Roth Principal Investments

BioStem Technologies, Inc.

Facility allows BioStem to sell up to $40M shares at its discretion over a 36-month term.
Market Open/Intraday purchases priced at 3% VWAP discount; Pre/Post-Market at 5% discount.
Pays $400k cash commitment fee (1% of facility) plus $75k legal and $50k QIU fees.
Exchange cap of 19.99% (3,585,375 shares) unless avg price >=$4.3056 or shareholder approval.
Proceeds intended for working capital and general corporate purposes; no obligation to draw.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.